Facing heavy pressure from industry, HHS rescinds health plan identifier
The Department of Health and Human Services has eliminated the need for health plans to use a standard unique health plan identifier, effective December 27.
HHS
Benefits Think Health agency reverses course on prescription drug coupon regulations
Following critical feedback and possible IRS conflicts, an HHS FAQ walks back recent pharmacy rules.
Zack Pace
CBIZ
Benefits Think Health agency reverses course on prescription drug coupon regulations
Following critical feedback and possible IRS conflicts, an HHS FAQ walks back recent pharmacy rules.
Zack Pace
CBIZ
New rule may greatly expand HRA usage
While the finalized regulation makes health reimbursement arrangements more accessible, employers should still continue to boost healthcare literacy, experts say.
Winners and losers under bold Trump plan to slash drug rebate deals
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
Winners and losers under bold Trump plan to slash drug rebate deals
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
Employer groups rally behind proposed Trump prescription drug pricing rule
The administration’s proposal would be a boon for employers and employees — and bring actual drug costs into the light.
Employer groups rally behind proposed Trump prescription drug pricing rule
The administration’s proposal would be a boon for employers and employees — and bring actual drug costs into the light.
Benefits Think Yes, it’s time to kill drug rebates
The Trump administration’s new prescription drug proposal is vital to correct an increasingly dysfunctional market for employer plan sponsors.
Michael Thompson
National Alliance of Healthcare Purchaser Coalitions
Trump health chief renews call to end key drug-pricing tactic
HHS' Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.
Senate confirms former drug executive Azar as Health Secretary
Ex-president of Eli Lilly's U.S. arm, Alex Azar, was confirmed to head the Department of Health and Human Services, setting a permanent replacement for Tom Price.
Trump pick to lead HHS faces senate questions on drug prices
Nominee Alex Azar was an executive at drugmaker Eli Lilly & Co. until January, a role that Democrats say raises concerns about whether he will take on high drug prices
Trump picks former Lilly drug executive as health secretary
President Donald Trump named former Eli Lilly & Co. executive Alex Azar to lead the Department of Health and Human Services.
Trump names acting HHS secretary
Eric Hargan has held various positions in the department, including deputy secretary, under President George W. Bush.
Trump’s health secretary Price resigns amid private jet scandal
Don J. Wright of Virginia will be named as acting secretary, effective at 11:59 p.m. on Friday.
Trump’s health secretary won’t say if administration still supports ACA repeal
Health and Human Services Secretary Tom Price wouldn’t say whether the Trump administration still supports repeal of the ACA, days after his party’s efforts to overhaul the law broke down.
Broker organizations plot next moves on MLR provision
Agent commissions still included as part of calculation in GOP health plan, but NAIFA, NAHU, other broker groups working to engineer a solution.
Broker organizations plot next moves on MLR provision
Agent commissions still included as part of calculation in GOP health plan, but NAIFA, NAHU, other broker groups working to engineer a solution.
What Price’s appointment means for employers
Benefits industry experts are urging the new Health and Human Services secretary not to repeal the Affordable Care Act without a definitive plan for what will replace it.
Senate confirms Price as HHS Secretary as ACA fight nears
The vote was 52-47, making Price the most contentious nominee for the position since at least President Jimmy Carter’s administration.
By
Anna Edney
